NOD2 and Crohn disease: This finding is consistent with the clinical observation (and preliminary evidence [36]) that (untreated) Crohn’s disease patients, who have a higher prevalence of NOD2 mutations than healthy controls, are not at an increased risk of S. aureus BSI.